Journal of comparative effectiveness research · 2015
Impact of treatment strategies for open angle glaucoma on intraocular pressure: the RiGOR study.
СтатьяНаблюдательное исследованиеПоддержка службы здравоохранения СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Coleman Anne L, Lum Flora C, Velentgas Priscilla, Su Zhaohui, Gliklich Richard E, RiGOR Study Group
Аннотация
AIMS: The RiGOR study's primary outcome measure was a 15% reduction in intraocular pressure (IOP) for patients with open-angle glaucoma at 1 year.
METHODS: Patients received treatment according to the ophthalmologist's usual practice.
RESULTS: A higher proportion of patients in the incisional and other surgery group achieved a 15% reduction in IOP than in the laser surgery or additional medication groups (82, 57, and 57% respectively). In multivariate regression analyses, incisional surgery patients were 2.7-times as likely as patients treated with additional medication to achieve a 15% reduction in IOP (odds ratio: 2.67; 95% CI: 2.01-3.57).
CONCLUSION: Incisional and other surgical procedures are effective treatments. There were no differences in treatment response by race or ethnicity.
METHODS: Patients received treatment according to the ophthalmologist's usual practice.
RESULTS: A higher proportion of patients in the incisional and other surgery group achieved a 15% reduction in IOP than in the laser surgery or additional medication groups (82, 57, and 57% respectively). In multivariate regression analyses, incisional surgery patients were 2.7-times as likely as patients treated with additional medication to achieve a 15% reduction in IOP (odds ratio: 2.67; 95% CI: 2.01-3.57).
CONCLUSION: Incisional and other surgical procedures are effective treatments. There were no differences in treatment response by race or ethnicity.
Предметные рубрики MeSH
Adrenergic alpha-2 Receptor AgonistsAdrenergic beta-AntagonistsAdultAgedAged, 80 and overBlack PeopleCarbonic Anhydrase InhibitorsFemaleGlaucoma, Open-AngleHispanic or LatinoHumansIntraocular PressureLaser TherapyMaleMiddle AgedParasympathomimeticsProstaglandins, SyntheticTrabeculectomyTreatment OutcomeYoung Adult